Non-Current Liabilities
Hedged Liability - Fair Value Hedge
Amgen Hedged Liability - Fair Value Hedge decreased by 13.7% to -$183M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.9%, from -$247M to -$183M. Over 5 years (FY 2020 to FY 2025), Hedged Liability - Fair Value Hedge shows a downward trend with a -22.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
First reportedQ4 2018
Last reportedQ1 2026Apr 30, 2026
Metric ID:
hedged_liability_fair_value_hedgeHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $424M | $371M | $284M | -$53M | -$210M | -$450M | -$437M | -$343M | -$436M | -$494M | -$314M | -$363M | -$345M | -$192M | -$343M | -$247M | -$186M | -$159M | -$161M | -$183M |
| QoQ Change | — | -12.5% | -23.5% | -118.7% | -296.2% | -114.3% | +2.9% | +21.5% | -27.1% | -13.3% | +36.4% | -15.6% | +5.0% | +44.3% | -78.6% | +28.0% | +24.7% | +14.5% | -1.3% | -13.7% |
| YoY Change | — | — | — | — | -149.5% | -221.3% | -253.9% | -547.2% | -107.6% | -9.8% | +28.1% | -5.8% | +20.9% | +61.1% | -9.2% | +32.0% | +46.1% | +17.2% | +53.1% | +25.9% |
Range-$494M – $424M
CAGR-16.2%
Avg YoY Growth-63.7%
Median YoY Growth+5.7%
Current Streak2 quarters decline
Hedged Liability - Fair Value Hedge at Other Companies
Frequently Asked Questions
- What is Amgen's hedged liability - fair value hedge?
- Amgen (AMGN) reported hedged liability - fair value hedge of -$183M in Q1 2026.
- How has Amgen's hedged liability - fair value hedge changed year-over-year?
- Amgen's hedged liability - fair value hedge increased by 25.9% year-over-year, from -$247M to -$183M.
- What is the long-term trend for Amgen's hedged liability - fair value hedge?
- Over 5 years (2020 to 2025), Amgen's hedged liability - fair value hedge has grown at a -22.2% compound annual growth rate (CAGR), from $566M to -$161M.